The gap between shorter- and longer-dated U.S. borrowing costs is widening, reflecting investors’ conviction that the Federal ...

U.S. stock futures are lower after last week's gains on increased expectations for a Federal Reserve rate cut in September.

Goldman's David Kostin sifted through earnings season, and one thing he noticed was that guidance for the rest of the year ...

UnitedHealth extends gains while Dayforce soars following a report that says it could be bought by private-equity firm Thoma ...

The Food and Drug Administration approved Novo Nordisk's popular weight-loss drug Wegovy to treat a form of liver disease.

Fresh off a 12% surge on the news that Warren Buffett's Berkshire Hathaway, as well as other leading investors, purchased the ...

U.S. stock index futures wavered on Monday, pausing after a recent rally as investors shifted their focus to earnings from ...

Novo Nordisk shares (DK:NOVO.B) (NVO) rose 4% in Copenhagen trade. The stock however has plunged 46% this year amid increased competition for its weight-loss drugs as well as turmoil at the company.

Dow, S&P 500, and Nasdaq futures are falling in premarket trading as the stock market braces for President Donald Trump's Ukraine meeting. The Federal Reserve's Jackson Hole Symposium and Retail ...

News that the U.S. could take a stake in Intel boosted the chip maker's stock. A deal could help advance President Trump's ...

Several major mergers and acquisitions have been announced in the U.S. over the last few months, including a deal uniting ...